[1]Hayek ER,Speakman E,Rehmus E.Acute doxorubicin cardiotoxicity[J].N Engl J Med，2005,352(23):2456-2457.[2] Swain SM, Whaley FS, Ewer MS.Congestive heart failure in patients treated with doxorubicin:a retrospective analysis of three trials[J]．Cancer,2003,97(11):2869-2879．[3] Le BrunLy V, Martin J, VenatBouvet L, et al. Cardiac toxicity with capecitabine, vinorelbine and trastuzumab therapy: case report and review of fluoropyrimidinerelated cardiotoxicity[J]. Oncology，2009,76(5):322-325.[4]Salvatore Patanè.Cardiotoxicity: cisplatin and long term cancer survivors[J].Cardiology，2014,175(1):201-202.[5]Ali M, Soto A, Maroongroge D. Electrocardiographic changes after Adriamycin chemotherapy[J]. Cancer，1979，43(2):465-471.[6] 林向慧，王升晔.恶性肿瘤患者放化疗相关的心脏毒性损伤[J].中华心血管病杂志, 2012,40(11):982-984.[7] Spodick DH.Effective management of pericardial neoplasia[J].Chest，2004，126(5):1395-1396.[8] 陈新．黄宛临床心电图学[M]．6版．北京：人民卫生出版社，2011：110-113．[9] 陈清启．心电图学[M]．2版．济南：山东科学技术出版社，2012：320-321．
2015, Vol. 24 
